These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 15225321)
1. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321 [TBL] [Abstract][Full Text] [Related]
2. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis]. Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648 [TBL] [Abstract][Full Text] [Related]
4. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations. Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391 [TBL] [Abstract][Full Text] [Related]
6. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand. Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660 [TBL] [Abstract][Full Text] [Related]
7. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis. Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance. Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the promoter region of methionine transporter gene Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948 [TBL] [Abstract][Full Text] [Related]
10. Detection of multidrug resistance in Mycobacterium tuberculosis. Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078 [TBL] [Abstract][Full Text] [Related]
11. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012. Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465 [TBL] [Abstract][Full Text] [Related]
12. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance. Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400 [TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis. Pandey B; Grover S; Kaur J; Grover A Sci Rep; 2019 Sep; 9(1):13617. PubMed ID: 31541138 [TBL] [Abstract][Full Text] [Related]
14. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains. Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779 [TBL] [Abstract][Full Text] [Related]
15. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021 [TBL] [Abstract][Full Text] [Related]
16. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates. Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744 [TBL] [Abstract][Full Text] [Related]
17. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. Shenai S; Rodrigues C; Mehta A Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777 [TBL] [Abstract][Full Text] [Related]
18. Ethambutol resistance testing by mutation detection. Johnson R; Jordaan AM; Pretorius L; Engelke E; van der Spuy G; Kewley C; Bosman M; van Helden PD; Warren R; Victor TC Int J Tuberc Lung Dis; 2006 Jan; 10(1):68-73. PubMed ID: 16466040 [TBL] [Abstract][Full Text] [Related]
19. The T120P or M172V mutation on Xu JT; Yu JF; Cheng T; Feng A; Yang P; Gu J; Yu HJ; Deng JY Emerg Microbes Infect; 2024 Dec; 13(1):2374030. PubMed ID: 39023395 [TBL] [Abstract][Full Text] [Related]